Canton Strategic Holdings (CNTN) EPS (Basic) (2021 - 2026)
Canton Strategic Holdings (CNTN) posted EPS (Basic) of -$0.23 for Q1 2026, up 46.26% on a QoQ basis from -$0.42 in Q4 2025, and up 76.93% year-over-year from -$0.13 in Q1 2025.
Canton Strategic Holdings (CNTN) EPS (Basic) (2021 - 2026) Analysis & Trends
Canton Strategic Holdings' EPS (Basic) history runs 6 years deep, the most recent figure standing at -$0.23 for Q1 2026.
- Quarterly EPS (Basic) rose 76.93% year-over-year to -$0.23 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$0.31 (up 93.54% YoY) and the FY2025 annual result came in at -$1.34, up 85.76% from the prior year.
- EPS (Basic) was -$0.23 for Q1 2026 at Canton Strategic Holdings, up from -$0.42 in the prior quarter.
- Across five years, EPS (Basic) topped out at -$0.02 in Q4 2022 and bottomed at -$2.92 in Q4 2024.
- A 5-year average of -$0.8 and a median of -$0.28 in 2022 frame the typical range for EPS (Basic).
- Annual changes were most pronounced in 2023 — EPS (Basic) sank 11265.93% — and 2025, when it surged 86.27%.
- Canton Strategic Holdings' EPS (Basic) stood at -$0.02 in 2022, then sank by 11265.93% to -$1.89 in 2023, then tumbled by 54.16% to -$2.92 in 2024, then surged by 85.48% to -$0.42 in 2025, then jumped by 46.26% to -$0.23 in 2026.
- Business Quant data shows CNTN's EPS (Basic) at -$0.23 in Q1 2026, -$0.42 in Q4 2025, and -$0.34 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 0.00 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 0.16 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 0.00 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 4.06 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 6.99 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 0.00 |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 7.59 |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -2.29 |
| 10 | Canton Strategic Holdings | 427.87 Mn | 427.87 Mn | - | -0.23 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.23 |
| Dec 31, 2025 | -0.42 |
| Sep 30, 2025 | -0.34 |
| Jun 30, 2025 | -0.64 |
| Mar 31, 2025 | -0.99 |
| Dec 31, 2024 | -2.92 |
| Sep 30, 2024 | -2.45 |
| Jun 30, 2024 | -2.42 |
| Mar 31, 2024 | -0.19 |
| Dec 31, 2023 | -1.89 |
| Sep 30, 2023 | -0.11 |
| Jun 30, 2023 | -0.16 |
| Mar 31, 2023 | -0.23 |
| Dec 31, 2022 | -0.02 |
| Sep 30, 2022 | -0.18 |
| Jun 30, 2022 | -0.14 |
| Mar 31, 2022 | -0.28 |
| Dec 31, 2021 | -0.06 |
| Sep 30, 2021 | -0.12 |
| Jun 30, 2021 | -0.20 |